Arax Advisory Partners’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62K | Buy |
218
+64
| +42% | +$18.2K | ﹤0.01% | 1140 |
|
|
2025
Q1 | $34.5K | Sell |
154
-20
| -11% | -$4.48K | ﹤0.01% | 1095 |
|
|
2024
Q4 | $39.8K | Buy |
174
+27
| +18% | +$6.18K | ﹤0.01% | 963 |
|
|
2024
Q3 | $35.9K | Buy |
147
+55
| +60% | +$13.4K | ﹤0.01% | 845 |
|
|
2024
Q2 | $17.6K | Buy |
92
+82
| +820% | +$15.7K | ﹤0.01% | 1018 |
|
|
2024
Q1 | $1.99K | Sell |
10
-12
| -55% | -$2.39K | ﹤0.01% | 1037 |
|
|
2023
Q4 | $3.79K | Hold |
22
| – | – | ﹤0.01% | 933 |
|
|
2023
Q3 | $3.25K | Sell |
22
-259
| -92% | -$38.3K | ﹤0.01% | 949 |
|
|
2023
Q2 | $61.5K | Buy |
281
+1
| +0.4% | +$219 | 0.01% | 434 |
|
|
2023
Q1 | $61.3K | Sell |
280
-93
| -25% | -$20.4K | 0.01% | 426 |
|
|
2022
Q4 | $77.6K | Sell |
373
-20
| -5% | -$4.16K | 0.01% | 376 |
|
|
2022
Q3 | $86K | Sell |
393
-142
| -27% | -$31.1K | 0.01% | 333 |
|
|
2022
Q2 | $112K | Sell |
535
-10
| -2% | -$2.09K | 0.02% | 300 |
|
|
2022
Q1 | $132K | Sell |
545
-3
| -0.5% | -$727 | 0.02% | 294 |
|
|
2021
Q4 | $143K | Sell |
548
-8
| -1% | -$2.09K | 0.02% | 282 |
|
|
2021
Q3 | $146K | Sell |
556
-19
| -3% | -$4.99K | 0.02% | 267 |
|
|
2021
Q2 | $142K | Buy |
+575
| New | +$142K | 0.02% | 274 |
|
|
2020
Q4 | $116K | Buy |
545
+17
| +3% | +$3.62K | 0.02% | 275 |
|
|
2020
Q3 | $90K | Buy |
528
+25
| +5% | +$4.26K | 0.02% | 284 |
|
|
2020
Q2 | $97K | Sell |
503
-4
| -0.8% | -$771 | 0.02% | 265 |
|
|
2020
Q1 | $75K | Sell |
507
-51
| -9% | -$7.54K | 0.02% | 277 |
|
|
2019
Q4 | $86K | Sell |
558
-24
| -4% | -$3.7K | 0.02% | 266 |
|
|
2019
Q3 | $79K | Buy |
582
+1
| +0.2% | +$136 | 0.02% | 266 |
|
|
2019
Q2 | $71K | Buy |
+581
| New | +$71K | 0.02% | 276 |
|